November CPAN Advocacy Chat: Save the Date

November 12, 2025, at 12 p.m. EST

Save the date and join Host Rose Gerber, MS, in November. CPAN Advocacy Chats are regular virtual 30-minute educational conversations about cancer advocacy and policy with a guest speaker invited to discuss issues important to patients and advocates. Summaries of previous Advocacy Chats are available on the CPAN website.

Previous Advocacy Chats

Each month, a special guest joins COA’s Director of Patient Advocacy & Education, Rose Gerber for a conversation on oncology and advocacy-related topics.

A prepared advocate is an effective advocate. That’s why COA and CPAN are working to provide advocates with the latest information on policy changes. As a new year begins, ensure you have the tools and knowledge you need to advocate for local, affordable cancer care.

View all past chats with full video playback, notes, and session slides.

Previous Advocacy Chats

Each month, a special guest joins COA’s Director of Patient Advocacy & Education, Rose Gerber for a conversation on oncology and advocacy-related topics.

A prepared advocate is an effective advocate. That’s why COA and CPAN are working to provide advocates with the latest information on policy changes. As a new year begins, ensure you have the tools and knowledge you need to advocate for local, affordable cancer care.

View all past chats with full video playback, notes, and session slides.

  • What’s Legal About Cancer? Insurance, Employment, Finances

    December 14, 2022 12:00 pm

    Monica Fawzy Bryant, Esq

    On December 14, 2022, COA’s Rose Gerber, MS, Director of Patient Advocacy & Education, and Triage Cancer’s Monica Fawzy Bryant, Esq, Chief Operating Officer, discussed important insurance, employment, and financial issues impacting cancer patients.

  • How Cancer Rehabilitation Benefits Patients

    November 9, 2022 12:00 pm

    Alaina Newell, PT, DPT

    Treating your cancer is essential. So is regaining your strength, mobility, and mental ability after treatment. Join CPAN Director of Patient Advocacy and Education Rose Gerber, MS, and guest speaker Alaina Newell, PT, DPT, for a discussion on the importance of cancer rehabilitation on Wednesday, November 9, at 12 p.m. ET.

  • How 340B In Big Health Systems is Hurting Patients

    October 12, 2022 12:00 pm

    Ted Okon, MBA

    The 340B Drug Pricing Program is meant to provide patients in need or patients in poorer areas with access to prescription drugs at significantly discounted prices. Is that what the program accomplishes currently? Join Rose Gerber and her guests Ted Okon and Nicolas Ferreyros on October 12, 2022 at 12 p.m. ET, for a discussion about this federal program gone awry.

  • The Psychosocial Impact of Cancer

    August 10, 2022 12:00 pm

    Lauren Chatalian, MSW, LCSW

    On August 10, 2022, Lauren Chatalian, MSW, LCSW, and Rose Gerber explored the psychosocial impact of a cancer diagnosis on a patient, their family, and friends. Chatalian, the director of advocacy at CancerCare, shared ways to promote effective communication between parents/guardians and children of families impacted by cancer in a developmentally appropriate manner. The chat focused on navigating practical concerns families may experience throughout the cancer continuum, such as loss of income, new health restrictions, and more.

  • National Organization for Rare Disorders

    July 13, 2022 12:00 pm

    Jill L. Pollander, RN, MSN

    On July 13 at 12 p.m. ET, COA’s Director of Patient Advocacy and Education Rose Gerber spoke with Jill Pollander, RN, MSN, the vice president of patient services at the National Organization for Rare Disorders (NORD). NORD conducts research into lesser known and new diseases, including cancer, to help physicians and patients achieve better outcomes. Additionally, NORD helps patients access the necessary care and treatment for their rare diagnoses, ensuring that these patients receive care no matter where they are. Currently, NORD assists almost 10,000 patients with treatment for their rare diseases.